JP Morgan Chase’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $233M | Sell |
3,325,095
-2,674,375
| -45% | -$178M | 0.01% | 696 |
|
|
2026
Q1 | $371M | Sell |
5,999,470
-216,931
| -3% | -$15.1M | 0.02% | 491 |
|
|
2025
Q4 | $413M | Buy |
6,216,401
+2,644
| +0% | +$171K | 0.03% | 450 |
|
|
2025
Q3 | $418M | Buy |
6,213,757
+59,165
| +1% | +$4.68M | 0.03% | 463 |
|
|
2025
Q2 | $537M | Buy |
6,154,592
+2,013,099
| +49% | +$158M | 0.04% | 405 |
|
|
2025
Q1 | $283M | Sell |
4,141,493
-199,886
| -5% | -$16.3M | 0.02% | 562 |
|
|
2024
Q4 | $338M | Sell |
4,341,379
-1,208,929
| -22% | -$89.5M | 0.03% | 493 |
|
|
2024
Q3 | $372M | Sell |
5,550,308
-1,160,675
| -17% | -$95.3M | 0.03% | 475 |
|
|
2024
Q2 | $761M | Buy |
6,710,983
+1,014,387
| +18% | +$128M | 0.06% | 275 |
|
|
2024
Q1 | $790M | Buy |
5,696,596
+43,977
| +0.8% | +$5.53M | 0.07% | 272 |
|
|
2023
Q4 | $701M | Buy |
5,652,619
+242,352
| +4% | +$24.8M | 0.07% | 279 |
|
|
2023
Q3 | $505M | Sell |
5,410,267
-7,262,910
| -57% | -$819M | 0.06% | 312 |
|
|
2023
Q2 | $1.63B | Buy |
12,673,177
+1,908,349
| +18% | +$231M | 0.18% | 126 |
|
|
2023
Q1 | $1.25B | Buy |
10,764,828
+117,732
| +1% | +$13.2M | 0.15% | 147 |
|
|
2022
Q4 | $1.21B | Buy |
10,647,096
+399,056
| +4% | +$43.8M | 0.16% | 142 |
|
|
2022
Q3 | $825M | Sell |
10,248,040
-135,409
| -1% | -$11.5M | 0.12% | 181 |
|
|
2022
Q2 | $774M | Sell |
10,383,449
-978,243
| -9% | -$89.3M | 0.11% | 200 |
|
|
2022
Q1 | $1.45B | Sell |
11,361,692
-370,428
| -3% | -$40.5M | 0.18% | 132 |
|
|
2021
Q4 | $1.57B | Sell |
11,732,120
-241,020
| -2% | -$34.6M | 0.18% | 128 |
|
|
2021
Q3 | $1.64B | Sell |
11,973,140
-3,020,880
| -20% | -$381M | 0.2% | 114 |
|
|
2021
Q2 | $1.6B | Buy |
14,994,020
+3,521,436
| +31% | +$338M | 0.19% | 126 |
|
|
2021
Q1 | $1.03B | Sell |
11,472,584
-762,900
| -6% | -$71.6M | 0.14% | 169 |
|
|
2020
Q4 | $1.13B | Sell |
12,235,484
-55,952
| -0.5% | -$5M | 0.17% | 141 |
|
|
2020
Q3 | $1.24B | Buy |
12,291,436
+153,276
| +1% | +$16M | 0.21% | 107 |
|
|
2020
Q2 | $1.23B | Sell |
12,138,160
-1,748,352
| -13% | -$156M | 0.24% | 96 |
|
|
2020
Q1 | $935M | Sell |
13,886,512
-535,464
| -4% | -$33.3M | 0.22% | 97 |
|
|
2019
Q4 | $789M | Sell |
14,421,976
-3,532
| -0% | -$168K | 0.15% | 149 |
|
|
2019
Q3 | $538M | Sell |
14,425,508
-2,773,704
| -16% | -$108M | 0.11% | 206 |
|
|
2019
Q2 | $627M | Sell |
17,199,212
-1,046,860
| -6% | -$32.9M | 0.12% | 174 |
|
|
2019
Q1 | $543M | Sell |
18,246,072
-2,653,928
| -13% | -$93.3M | 0.11% | 200 |
|
|
2018
Q4 | $626M | Buy |
20,900,000
+7,276,568
| +53% | +$231M | 0.14% | 152 |
|
|
2018
Q3 | $487M | Buy |
13,623,432
+2,079,004
| +18% | +$64.5M | 0.09% | 231 |
|
|
2018
Q2 | $274M | Buy |
11,544,428
+1,191,500
| +12% | +$25.3M | 0.06% | 349 |
|
|
2018
Q1 | $192M | Buy |
10,352,928
+845,000
| +9% | +$12.5M | 0.04% | 438 |
|
|
2017
Q4 | $136M | Buy |
9,507,928
+73,900
| +0.8% | +$961K | 0.03% | 524 |
|
|
2017
Q3 | $107M | Buy |
9,434,028
+4,954,712
| +111% | +$87.6M | 0.02% | 599 |
|
|
2017
Q2 | $81.9M | Buy |
4,479,316
+660,504
| +17% | +$12.2M | 0.02% | 701 |
|
|
2017
Q1 | $80.9M | Buy |
3,818,812
+3,742,456
| +4,901% | +$73M | 0.02% | 706 |
|
|
2016
Q4 | $1.14M | Buy |
76,356
+27,716
| +57% | +$491K | ﹤0.01% | 3373 |
|
|
2016
Q3 | $1.07M | Sell |
48,640
-371,052
| -88% | -$8.26M | ﹤0.01% | 3100 |
|
|
2016
Q2 | $8.32M | Buy |
419,692
+382,520
| +1,029% | +$6.51M | ﹤0.01% | 1956 |
|
|
2016
Q1 | $631K | Sell |
37,172
-42,048
| -53% | -$702K | ﹤0.01% | 3264 |
|
|
2015
Q4 | $1.62M | Buy |
79,220
+62,400
| +371% | +$1.3M | ﹤0.01% | 2864 |
|
|
2015
Q3 | $362K | Buy |
+16,820
| New | +$375K | ﹤0.01% | 3536 |
|
|
2015
Q2 | – | Sell |
-265,676
| Closed | -$4.14M | – | 4047 |
|
|
2015
Q1 | $4.14M | Buy |
265,676
+243,704
| +1,109% | +$3.68M | ﹤0.01% | 2477 |
|
|
2014
Q4 | $302K | Buy |
+21,972
| New | +$269K | ﹤0.01% | 3868 |
|
|
2014
Q3 | – | Sell |
-20,856
| Closed | -$207K | – | 4198 |
|
|
2014
Q2 | $207K | Sell |
20,856
-41,092
| -66% | -$364K | ﹤0.01% | 3363 |
|
|
2014
Q1 | $641K | Sell |
61,948
-14,380
| -19% | -$149K | ﹤0.01% | 3043 |
|
|
2013
Q4 | $676K | Sell |
76,328
-59,164
| -44% | -$468K | ﹤0.01% | 3332 |
|
|
2013
Q3 | $956K | Sell |
135,492
-38,808
| -22% | -$246K | ﹤0.01% | 3296 |
|
|
2013
Q2 | $978K | Buy |
+174,300
| New | +$835K | ﹤0.01% | 3273 |
|
Other funds holding DXCM
JP Morgan Chase's DXCM Position: Q2 2026 in Review
JP Morgan Chase reduced its DexCom (DXCM) stake by 45% in Q2 2026, selling an estimated $178M and leaving 3,325,095 shares worth $233M. The position accounts for 0.01% of the portfolio, ranked #696.
JP Morgan Chase first reported a position in DXCM in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.64B in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- JP Morgan Chase held 3,325,095 shares of DexCom worth $233M as of Q2 2026.
- JP Morgan Chase sold 2,674,375 DexCom shares in Q2 2026, an estimated $178M.
- DexCom made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #696 holding.
- JP Morgan Chase first reported a position in DexCom in Q2 2013 and has held it in 51 quarters since.
- JP Morgan Chase's DexCom position peaked at $1.64B in Q3 2021.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.